Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells

類似資料

• Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)
  著者:: Nakano, Dan, 等
  出版事項: (2020)
• Effects of a DPP4 Inhibitor on Progression of NASH-related HCC and the p62/ Keap1/Nrf2-Pentose Phosphate Pathway in a Mouse Model
  著者:: Kawaguchi, Takumi, 等
  出版事項: (2019)
• MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
  著者:: Takumi Kawaguchi, 等
  出版事項: (2022-04-01)
• Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
  著者:: Takumi Kawaguchi, 等
  出版事項: (2022-04-01)
• Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular Carcinoma
  著者:: Tsuchihashi, Jin, 等
  出版事項: (2021)